AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Eastgate Biotech Corp.

$0 -$0.00 (-10.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
5.56M
AVG Volume
104
Trailing/Forward PE
-1.42/-
PEG ratio
-0.2
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
-50K050K100K150K200K15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
ETBI Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
17 Q344.11K
17 Q222.66K
17 Q1-1.08K
16 Q40
16 Q393.83K
16 Q2165.32K
16 Q1133.11K
15 Q4132.03K
15 Q3131.72K
15 Q258.54K
Net Income (USD) · TTM
-6M-4M-2M015 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
ETBI Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
17 Q3-4.23M
17 Q2-3.32M
17 Q1-3.23M
16 Q4-2.98M
16 Q3-2.87M
16 Q2-2.99M
16 Q1-3.19M
15 Q4-4.28M
15 Q3-4.51M
15 Q2-4.63M
Operating Income (USD) · TTM
-6M-4M-2M015 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
ETBI Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
17 Q3-3.79M
17 Q2-2.77M
17 Q1-2.89M
16 Q4-2.63M
16 Q3-2.72M
16 Q2-2.85M
16 Q1-3.06M
15 Q4-4.17M
15 Q3-4.41M
15 Q2-4.54M
EBITDA (USD) · TTM
-6M-4M-2M015 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
ETBI EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
17 Q3-3.53M
17 Q2-2.23M
17 Q1-2.64M
16 Q4-3.16M
16 Q3-3.05M
16 Q2-3.42M
16 Q1-3.79M
15 Q4-4.13M
15 Q3-4.37M
15 Q2-4.5M
Cash Flows (USD) · TTM
-2M-1.5M-1M-500K015 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
ETBI Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
17 Q3-1.75M
17 Q2-528.31K
17 Q1-407.45K
16 Q4-389.48K
16 Q3-239.5K
16 Q2-252.03K
16 Q1-405.9K
15 Q4-568.44K
15 Q3-626.7K
15 Q2-899.23K
EPS (USD) · TTM
-0.06-0.04-0.02015 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
ETBI EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
17 Q3-0.01
17 Q2-0.01
17 Q1-0.01
16 Q4-0.01
16 Q3-0.01
16 Q2-0.01
16 Q1-0.01
15 Q4-0.03
15 Q3-0.04
15 Q2-0.06
Expenses (USD) · TTM
02M4M6MR&DSG&ACapex15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
ETBI Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
17 Q33.75M
17 Q22.75M
17 Q12.88M
16 Q42.63M
16 Q32.8M
16 Q22.99M
16 Q13.18M
15 Q44.28M
15 Q34.53M
15 Q24.62M
Shares Outstanding · TTM
-1.5M-1M-500K015 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
ETBI Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
17 Q3-465.35K
17 Q2-465.47K
17 Q1-465.58K
16 Q4-832
16 Q3-98
16 Q2-433
16 Q1-656
15 Q4-854.15K
15 Q3-1.07M
15 Q2-1.17M
Free Cash Flow Yield
-200000%-150000%-100000%-50000%0%med -52.51%Dec 24May 25Sep 25Jan 26May 26Sep 26
ETBI Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-58.35%
Sep 26-58.35%
Aug 26-52.51%
Aug 26-52.51%
Aug 26-52.51%
Aug 26-52.51%
Jul 26-52.51%
Jul 26-52.51%
Jul 26-52.51%
Jul 26-52.51%
Jul 26-52.51%
Jun 26-52.51%
Jun 26-52.51%
Jun 26-52.51%
Jun 26-52.51%
May 26-52.51%
May 26-52.51%
May 26-157.54%
May 26-157.54%
May 26-157.54%
Apr 26-157.54%
Apr 26-157.54%
Apr 26-157.54%
Apr 26-157.54%
Mar 26-157.54%
Mar 26-157.54%
Mar 26-157.54%
Mar 26-157.54%
Feb 26-157.54%
Feb 26-157.54%
Feb 26-196.93%
Feb 26-196.93%
Jan 26-196.93%
Jan 26-196.93%
Jan 26-52.51%
Jan 26-52.51%
Jan 26-52.51%
Dec 25-52.51%
Dec 25-52.51%
Dec 25-52.51%
Dec 25-52.51%
Nov 25-52.51%
Nov 25-52.51%
Nov 25-52.51%
Nov 25-52.51%
Oct 25-52.51%
Oct 25-52.51%
Oct 25-52.51%
Oct 25-52.51%
Oct 25-52.51%
Sep 25-52.51%
Sep 25-52.51%
Sep 25-52.51%
Sep 25-52.51%
Aug 25-52.51%
Aug 25-39.39%
Aug 25-39.39%
Aug 25-39.39%
Aug 25-39.39%
Jul 25-39.39%
Jul 25-39.39%
Jul 25-39.39%
Jul 25-39.39%
Jun 25-1575.41%
Jun 25-39.39%
Jun 25-39.39%
Jun 25-39.39%
May 25-39.39%
May 25-1575.41%
May 25-39.39%
May 25-39.39%
May 25-39.39%
Apr 25-39.39%
Apr 25-39.39%
Apr 25-39.39%
Mar 25-39.39%
Mar 25-39.39%
Feb 25-35.01%
Feb 25-157541.32%
Feb 25-35.01%
Jan 25-1575.41%
Jan 25-35.01%
Jan 25-35.01%
Dec 24-1575.41%
Dec 24-1575.41%
Dec 24-35.01%
Dec 24-35.01%
Nov 24-35.01%
Nov 24-35.01%
Oct 24-35.01%
Oct 24-35.01%
Oct 24-35.01%
Sep 24-35.01%
Sep 24-35.01%
Aug 24-35.01%
Jul 24-35.01%
Jul 24-35.01%
Jul 24-35.01%
Jun 24-35.01%
Jun 24-35.01%
Price to Sales
050100150med 75.61Oct 24Mar 25Jul 25Oct 25Feb 26May 26Sep 26
ETBI Price to Sales by quarter
PeriodPrice to Sales
Sep 2668.05
Sep 2668.05
Aug 2675.61
Aug 2675.61
Aug 2675.61
Aug 2675.61
Jul 2675.61
Jul 2675.61
Jul 2675.61
Jul 2675.61
Jul 2675.61
Jun 2675.61
Jun 2675.61
Jun 2675.61
Jun 2675.61
May 2675.61
May 2675.61
May 2625.2
May 2625.2
May 2625.2
Apr 2625.2
Apr 2625.2
Apr 2625.2
Apr 2625.2
Mar 2625.2
Mar 2625.2
Mar 2625.2
Mar 2625.2
Feb 2625.2
Feb 2625.2
Feb 2620.16
Feb 2620.16
Jan 2620.16
Jan 2620.16
Jan 2675.61
Jan 2675.61
Jan 2675.61
Dec 2575.61
Dec 2575.61
Dec 2575.61
Dec 2575.61
Nov 2575.61
Nov 2575.61
Nov 2575.61
Nov 2575.61
Oct 2575.61
Oct 2575.61
Oct 2575.61
Oct 2575.61
Oct 2575.61
Sep 2575.61
Sep 2575.61
Sep 2575.61
Sep 2575.61
Aug 2575.61
Aug 25100.81
Aug 25100.81
Aug 25100.81
Aug 25100.81
Jul 25100.81
Jul 25100.81
Jul 25100.81
Jul 25100.81
Jun 252.52
Jun 25100.81
Jun 25100.81
Jun 25100.81
May 25100.81
May 252.52
May 25100.81
May 25100.81
May 25100.81
Apr 25100.81
Apr 25100.81
Apr 25100.81
Mar 25100.81
Mar 25100.81
Feb 25113.41
Feb 250.03
Feb 25113.41
Jan 252.52
Jan 25113.41
Jan 25113.41
Dec 242.52
Dec 242.52
Dec 24113.41
Dec 24113.41
Nov 24113.41
Nov 24113.41
Oct 24113.41
Oct 24113.41
Oct 24113.41
Sep 24113.41
Sep 24113.41
Aug 24113.41
Jul 24113.41
Jul 24113.41
Jul 24113.41
Jun 24113.41
Jun 24113.41
Eastgate Biotech Corp.
ETBI
Stockpicker

Video analysis: ETBI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.